ABVC BioPharma Analyst Ratings
ABVC BioPharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2022 | — | Maxim Group | Downgrades | Buy → Hold |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/16/2022 | — | Maxim 集团 | 降级 | 买入 → 持有 |
What is the target price for ABVC BioPharma (ABVC)?
ABVC 生物制药（ABVC）的目标价格是多少？
The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on November 16, 2022. The analyst firm set a price target for $0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
美心集团于2022年11月16日公布了ABVC BioPharma（纳斯达克股票代码：ABVC）的最新目标股价。该分析公司将目标股价设定为0.00美元，预计ABVC将在12个月内跌至-100.00％（下跌幅度可能为-100.00％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for ABVC BioPharma (ABVC)?
ABVC BioPharma（ABVC）的最新分析师评级是多少？
The latest analyst rating for ABVC BioPharma (NASDAQ: ABVC) was provided by Maxim Group, and ABVC BioPharma downgraded their hold rating.
ABVC BioPharma（纳斯达克股票代码：ABVC）的最新分析师评级由Maxim集团提供，ABVC BioPharma下调了其持有评级。
When is the next analyst rating going to be posted or updated for ABVC BioPharma (ABVC)?
ABVC BioPharma（ABVC）的下一个分析师评级何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ABVC BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ABVC BioPharma was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与ABVC BioPharma的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应获得4个评级。ABVC BioPharma的最后一次评级是在2022年11月16日提交的，因此您应该预计下一个评级将在2023年11月16日左右公布。
Is the Analyst Rating ABVC BioPharma (ABVC) correct?
分析师评级ABVC BioPharma（ABVC）是否正确？
While ratings are subjective and will change, the latest ABVC BioPharma (ABVC) rating was a downgraded with a price target of $0.00 to $0.00. The current price ABVC BioPharma (ABVC) is trading at is $0.76, which is out of the analyst's predicted range.
尽管评级是主观的，并将发生变化，但最新的ABVC BioPharma（ABVC）评级下调，目标股价为0.00美元至0.00美元。ABVC BioPharma（ABVC）目前的交易价格为0.76美元，超出了分析师的预测区间。